Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial-
Not available.
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2026-07-01
|
| Series: | Haematologica |
| Acceso en liña: | https://haematologica.org/article/view/14318 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|